Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases

被引:73
|
作者
Park, Hyejin [1 ,2 ]
Kam, Tae-In [1 ,2 ]
Dawson, Ted M. [1 ,2 ,3 ,4 ,5 ]
Dawson, Valina L. [1 ,2 ,3 ,4 ,6 ]
机构
[1] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA
[4] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA
[5] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA
来源
CELL DEATH REGULATION IN HEALTH AND DISEASE - PT C | 2020年 / 353卷
基金
美国国家卫生研究院;
关键词
MIGRATION INHIBITORY FACTOR; APOPTOSIS-INDUCING-FACTOR; POLY(ADP-RIBOSE) GLYCOHYDROLASE; CRYSTAL-STRUCTURE; MOLECULAR-MECHANISMS; MITOCHONDRIAL AIF; MOUSE MODEL; FACTOR MIF; POLYMERASE; PARP;
D O I
10.1016/bs.ircmb.2019.12.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Disruption of cellular functions with aging-induced accumulation of neuronal stressors causes cell death which is a common feature of neurodegenerative diseases. Studies in a variety of neurodegenerative disease models demonstrate that poly (ADP-ribose) (PAR)-dependent cell death, also named parthanatos, is responsible for neuronal loss in neurological diseases, such as Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS). Parthanatos has distinct features that differ from caspase-dependent apoptosis, necrosis or autophagic cell death. Parthanatos can be triggered by the accumulation of PAR due to overactivation of PAR polymerase-1 (PARP-1). Excess PAR, induces the mitochondrial release apoptosis-inducing factor (AIF), which binds to macrophage migration inhibitory factor (MIF) carrying MIF into the nucleus where it cleaves genomic DNA into large fragments. In this review, we will discuss the molecular mechanisms of parthanatos and their role in neurodegenerative diseases. Furthermore, we will discuss promising therapeutic interventions within the pathological PAR signaling cascade that could be designed to halt the progression of neurodegeneration.
引用
收藏
页码:1 / 29
页数:29
相关论文
共 50 条
  • [41] Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities
    Xu, Xiaoxue
    Sun, Bowen
    Zhao, Chuansheng
    NEUROBIOLOGY OF DISEASE, 2023, 187
  • [42] Multiple facets of poly(ADP-ribose) polymerase-1 in neurological diseases
    Chandra Shaker Sriram
    Ashok Jangra
    Rajaram Mohanrao Madhana
    Satendra Singh Gurjar
    Pritam Mohan
    Babul Kumar Bezbaruah
    NeuralRegenerationResearch, 2015, 10 (01) : 49 - 51
  • [43] The poly(ADP-ribose) glycohydrolase inhibitor gallotannin blocks oxidative astrocyte death
    Ying, WH
    Swanson, RA
    NEUROREPORT, 2000, 11 (07) : 1385 - 1388
  • [44] Inhibition of poly(ADP-ribose) polymerase by arsenite
    Yager, JW
    Wiencke, JK
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 1997, 386 (03) : 345 - 351
  • [45] MODE OF ACTION OF POLY(ADP-RIBOSE) GLYCOHYDROLASE
    BROCHU, G
    DUCHAINE, C
    THIBEAULT, L
    LAGUEUX, J
    SHAH, GM
    POIRIER, GG
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1994, 1219 (02): : 342 - 350
  • [46] Poly(ADP-ribose)glycohydrolase is an upstream regulator of Ca2+ fluxes in oxidative cell death
    C. Blenn
    P. Wyrsch
    J. Bader
    M. Bollhalder
    Felix R. Althaus
    Cellular and Molecular Life Sciences, 2011, 68 : 1455 - 1466
  • [47] Mitotic functions of poly(ADP-ribose) polymerases
    Slade, Dea
    BIOCHEMICAL PHARMACOLOGY, 2019, 167 : 33 - 43
  • [48] NOVEL INHIBITORS OF POLY(ADP-RIBOSE) GLYCOHYDROLASE
    AOKI, K
    NISHIMURA, K
    ABE, H
    MARUTA, H
    SAKAGAMI, H
    HATANO, T
    OKUDA, T
    YOSHIDA, T
    TSAI, YJ
    UCHIUMI, F
    TANUMA, S
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1158 (03) : 251 - 256
  • [49] Poly (ADP-ribose) polymerase and brain ischemia
    Traystman, RJ
    Kofler, J
    Sawada, M
    Martin, LJ
    Dawson, VL
    Hurn, PD
    MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA, 2003, 1252 : 21 - 29
  • [50] Oncogenic activity of poly (ADP-ribose) glycohydrolase
    Marques, Maud
    Jangal, Maika
    Wang, Li-Chun
    Kazanets, Anna
    da Silva, Sabrina Daniela
    Zhao, Tiejun
    Lovato, Amanda
    Yu, Henry
    Jie, Su
    del Rincon, Sonia
    MacKey, John
    Damaraju, Sambasivarao
    Alaoui-Jamali, Moulay
    Witcher, Michael
    ONCOGENE, 2019, 38 (12) : 2177 - 2191